Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ORGOthis companyOrganogenesis Holdings Inc.	$0.82	32.38×	1.51×	1.17×	9.41×	422.9%	75.6%	9.9%	6.6%	8.5%	8.5%	-3.7%	0.31×	0.53×	0×	3.62×	0.0%	2	1.23	2	C+
ANGOAngioDynamics, Inc.	$12.07	-12.4×	2.65×	1.42×	818×	-138.7%	54.6%	-12.5%	-11.5%	-21.5%	-20.7%	0.1%	0×	-110.38×	-133.54×	2.19×	0.0%	5	2.38	2	C+
CMPXCompass Therapeutics, Inc.	$0.80	-12.79×	4.3×	0×	-12.7×	-84.0%	0.0%	0.0%	0.0%	-33.8%	-35.3%	-5.8%	0.05×	0.32×	0×	15.02×	0.0%	3	-0.29	2	C+
EBSEmergent BioSolutions Inc.	$6.04	12.61×	1.27×	0.89×	4.32×	-48.4%	47.2%	14.8%	7.1%	10.1%	5.9%	23.7%	1.09×	1.54×	1.86×	5.01×	0.0%	4	0.4	1	C-
EOLSEvolus, Inc.	$6.75	-8.31×	-18.55×	1.44×	-23.52×	27.2%	64.9%	-12.7%	-17.4%	223.5%	-24.6%	-11.8%	-6.71×	-4.49×	-1.91×	1.9×	0.0%	3	-1.44	2	C
MNPRMonopar Therapeutics Inc.	$72.70	-35.3×	3.51×	0×	-30.78×	-87.9%	0.0%	0.0%	0.0%	-10.0%	-12.1%	-2.5%	0×	4.5×	0×	51.35×	0.0%	0	64.41	2	C
Peer median	—	-12.4×	2.65×	0.89×	-12.7×	-84.0%	47.2%	0.0%	0.0%	-10.0%	-20.7%	-2.5%	0×	0.32×	0×	5.01×	0.0%	3	0.4	2	—